Professor of Psychiatry, University Mich Medical School
Psychiatry
Dr. John F. Greden, MD
|
|
Give Review
John F. Greden, MD practices Psychiatry. He graduated from University of Minnesota Medical School. University of Minnesota Medical School has a rank of 40 in research and a 10 in primary care He over the years received 4 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Women's Health" and "Men's Health". John Greden is a published doctor. He published 100 publications, including: 'Extended antidepressant maintenance and discontinuation syndromes.'
Publications
- Public-academic partnerships: working together to meet the needs of Army National Guard soldiers: an academic-military partnership.
- Does antidepressant step therapy fuel the law of unintended consequences?
- Buddy-to-Buddy, a citizen soldier peer support program to counteract stigma, PTSD, depression, and suicide.
- Suicidality and risk of suicide--definition, Drug safety concerns, and a necessary target for Drug development: a brief report.
- Suicidality and risk of suicide--definition, Drug safety concerns, and a necessary target for Drug development: a consensus statement.
- In memory of Elizabeth Young.
- The University of Michigan Honest Broker: a Web-based service for clinical and translational research and practice.
- Treating depression and pain.
- Criminal background checks for psychiatry? Michigan's Mental health exceptionalism.
- What happened to lithium? Antidepressant augmentation in clinical settings.
- Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III.
- The "Honest Broker" method of integrating interdisciplinary research data.
- Diagnosing and treating depression earlier and preventing recurrences: still neglected after all these years.
- Physical symptoms of depression: unmet needs.
- Unmet need: what justifies the search for a new antidepressant?
- Relative Efficacy of Unilateral and Bilateral Electroconvulsive Therapy in Melancholia.
- The burden of recurrent depression: causes, consequences, and future prospects.
- The burden of disease for treatment-resistant depression.
- Insomnia, self-medication, and relapse to Alcoholism.
- Treatment guidelines for depression in pregnancy.
- Serotonin dysregulation in adolescents with Major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion.
- Extended antidepressant maintenance and discontinuation syndromes.
- Do long-term treatments alter lifetime course? Lessons learned, actions needed.
- Serotonin: how much we have learned! So much to discover...
- Depression in children with autism/pervasive developMental disorders: a case-control family history study.
- Sleep-onset rapid eye movement after electroconvulsive therapy is more frequent in patients who respond less well to electroconvulsive therapy.
- Electroconvulsive treatment in adolescents with pharmacotherapy-refractory depression.
- Polysomnographic studies in patients referred for ECT: pre-ECT studies.
- Fluoxetine versus phenelzine in atypical depression.
- Alcohol inhibits lipopolysaccharide-induced tumor necrosis factor alpha gene expression by peripheral blood mononuclear cells as measured by reverse transcriptase PCR ...
- Life events and depression in children with pervasive developMental disorders.
- Dissociation between pituitary and adrenal suppression to dexamethasone in depression.
- Immune function in Alcoholism: a controlled study.
- Cholinergic Hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls.
- Dysthymia characteristic of heavy Alcohol use in depressed adolescents.
- Multiple HPA profiles in endogenous depression: effect of age and sex on cortisol and beta-endorphin.
- Depression in stroke rehabilitation.
- Sleep deprivation in depressed adolescents and psychiatric controls.
- Psychomotor monitoring: a promise being fulfilled?
- Antidepressant maintenance medications: when to discontinue and how to stop.
- The DST as a predictor of outcome in depression: a meta-analysis.
- Selective effect of Alcohol on cellular immune responses of lymphocytes from AIDS patients.
- Clinical characteristics of patients with concurrent major depressive Disorder and panic Disorder.
- Introduction. Part III. New agents for the treatment of depression.
- Shortened REM latency PostECT is associated with rapid recurrence of Depressive symptomatology.
- Suppression of tumor necrosis factor production by Alcohol in lipopolysaccharide-stimulated culture.
- Covariance of positive and negative symptoms during neuroleptic treatment in Schizophrenia: a replication.
- Long-term treatment for lifetime Disorders?
- Selective inhibition by Alcohol and cortisol of natural killer cell activity of lymphocytes from cord blood.
- A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.
- Neuroendocrine diagnostic criteria for depression [proceedings].
- Plasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression.
- Decrease in speech pause times with treatment of endogenous depression.
- Caffeine-withdrawal headache: a clinical profile.
- Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression.
- Serial dexamethasone suppression tests in affective Disorders.
- The effect of amphetamine on plasma cortisol in patients with endogenous and non-endogenous depression.
- Caffeinism associated with greater use of other psychotropic agents.
- Speech pause time: a marker of psychomotor retardation among endogenous Depressives.
- Psychomotor function in affective Disorders: an overview of new monitoring techniques.
- The Carroll rating scale for depression. I. Development, reliability and validation.
- Changes in serial dexamethasone suppression tests among unipolar Depressive receiving electroconvulsive treatment.
- Neuroendocrine evaluation of depression in borderline patients.
- Somatic manifestations of caffeinism.
- Dexamethasone suppression test.
- Sleep EEG, depression rating scales, and diagnosis.
- Application of biological markers in depression secondary to thyrotoxicosis.
- Interference by carbamazepine with the dexamethasone suppression test.
- Serial dexamethasone suppression tests among rapidly cycling Bipolar patients.
- EEG studies of sleep in the diagnosis of depression.
- Caffeine and benzodiazepine use.
- Neuroendocrine dysfunction in genetic subtypes of primary unipolar depression.
- Does patient contact change racial perceptions?
- Dexamethasone suppression test in primary degenerative dementia.
- Impaired lymphocyte function in Depressive illness.
- The dexamethasone suppression test in patients with Alcoholism.
- Imipramine-induced tremor: effects of a beta-adrenergic blocking agent.
- Antidepressant withdrawal symptoms treated with anticholinergic agents.
- Depressive pseudodementia: a suggested diagnostic profile.
- Biological markers of melancholia and reclassification of depressive Disorders.
- Antidepressant withdrawal-induced activation (hypomania and mania): is withdrawal-induced cholinergic overdrive causally significant?
- The effect of dexamethasone on sleep: preliminary results in eleven patients.
- Possible cholinergic mechanism in reserpine and tardive dyskinesia.
- The dexamethasone suppression test in repeated hospitalizations.
- Antidepressant withdrawal syndromes: evidence for supersensitivity of cholinergic system as an etiologic factor.
- The DST in borderline patients.
- Facial EMG activity levels predict treatment outcome in depression.
- Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus.
- Dexamethasone suppression test and selection of antidepressant medications.
- Clinical psychiatry conference: biological and family indicators in depression.
- Antidepressant withdrawal syndromes: evidence supporting the cholinergic overdrive hypothesis.
- Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.
- Cholinergic syndrome from psychotropic withdrawal in a marijuana Abuser.
- Antidepressant withdrawal phenomena.
- Plasma measures of B-endorphin-like immunoreactivity in Depressives and other psychiatric subjects.
- Platelet alpha 2-adrenergic receptors in major depressive Disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment.
- Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria.
- Neurotransmitter studies of neuroendocrine pathology in depression.
- Antidepressant withdrawal-induced activation (hypomania and mania): mechanism and theoretical significance.
Schools
University of Mn Med Sch
Harbor UCLA Med Center
University Of Minnesota
Walter Reed Army Med Center
Procedures Preformed
- Psychiatric Evaluation
Conditions Treated
- Alcohol-Induced Mental Disorders
- Alcoholism (Alcohol Dependence)
- Anxiety
- Attention Deficit Hyperactivity Disorder (ADHD)
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Women's Health
- Men's Health
Education
-
University of Minnesota at Fairview -
Harbor - UCLA Medical Center -
University of Minnesota Medical School
Hospital
-
University of Michigan Hospitals and Health Centers
Helpful Reviews
Similar Doctors
|
|
Dr. Marcia A. Valenstein, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sarah A. Zakaria, MD |
|
|
Dr. Jonathan M. Metzl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Wurzelmann, MD |